402 related articles for article (PubMed ID: 30635824)
1. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
[TBL] [Abstract][Full Text] [Related]
2. [The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis].
Makshakov GS; Nazarov VD; Totolyan NA; Lapin SV; Mazing AV; Emanuel VL; Krasnov VS; Shumilina MV; Skoromets AA; Evdoshenko EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10. Vyp. 2):4-10. PubMed ID: 29359727
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
[TBL] [Abstract][Full Text] [Related]
6. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
Front Immunol; 2019; 10():641. PubMed ID: 30984199
[No Abstract] [Full Text] [Related]
7. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
Krakauer M; Schaldemose Nielsen H; Jensen J; Sellebjerg F
Acta Neurol Scand; 1998 Sep; 98(3):161-5. PubMed ID: 9786611
[TBL] [Abstract][Full Text] [Related]
11. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
[TBL] [Abstract][Full Text] [Related]
12. Free light chains in the CSF in multiple sclerosis.
Bracco F; Gallo P; Menna R; Battistin L; Tavolato B
J Neurol; 1987 Jun; 234(5):303-7. PubMed ID: 3112315
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
[TBL] [Abstract][Full Text] [Related]
14. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
[TBL] [Abstract][Full Text] [Related]
15. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
Rudick RA; Cookfair DL; Simonian NA; Ransohoff RM; Richert JR; Jacobs LD; Herndon RM; Salazar AM; Fischer JS; Granger CV; Goodkin DE; Simon JH; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munchsauer FE; O'Reilly K; Priore RL; Whitham RH
J Neuroimmunol; 1999 Jan; 93(1-2):8-14. PubMed ID: 10378864
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
Arneth B; Birklein F
Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
[TBL] [Abstract][Full Text] [Related]
19. Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
Lotan I; Ganelin-Cohen E; Tartakovsky E; Khasminsky V; Hellmann MA; Steiner I; Ben-Zvi I; Livneh A; Golderman S; Kaplan B
Mult Scler Relat Disord; 2020 Sep; 44():102339. PubMed ID: 32599469
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis.
Hegen H; Milosavljevic D; Schnabl C; Manowiecka A; Walde J; Deisenhammer F; Presslauer S
Clin Chem Lab Med; 2018 Jul; 56(8):1383-1391. PubMed ID: 29648995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]